Endogenous Metabolite (EM) Information
| Endogenous Metabolite (EM) Information | ||||||
|---|---|---|---|---|---|---|
| EM ID |
EM00080
|
|||||
| EM Name |
Indoxyl sulfate
|
|||||
| Synonyms |
Indoxyl sulfate; 3-Indoxyl sulfate; Indoxylsulfuric acid; 1H-indol-3-yl hydrogen sulfate; 3-Indoxylsulfuric acid; 3-SULFOOXY-1H-INDOLE; UNII-KT0QA88913; Indol-3-yl sulfate; indol-3-yl sulphate; 1H-indol-3-yloxidanesulfonic acid; KT0QA88913; IOS; Indican (metabolic indican); indoxyl sulphate; 3-indolyl sulfate; indoxyl-3-sulphate; Indican (metabolic indolyl sulfate); Indoxyl sulfic acid; 3-Indoxyl sulphate; 1H-Indol-3-ol, hydrogen sulfate (ester); AC1L1UTK; AC1Q6XJD; 3-indolyl hydrogen sulfate
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=10258"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C8H7NO4S
|
|||||
| Canonical SMILES |
BXFFHSIDQOFMLE-UHFFFAOYSA-N
|
|||||
| InChI |
InChI=1S/C8H7NO4S/c10-14(11,12)13-8-5-9-7-4-2-1-3-6(7)8/h1-5,9H,(H,10,11,12)
|
|||||
| InChIKey |
BXFFHSIDQOFMLE-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 487-94-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 213.21 | Topological Polar Surface Area | 87.8 | ||
| Heavy Atom Count | 14 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
1.3
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:43355
|
|||||
| DT(s) "handling" This EM | BCRP | Transporter Info | Breast cancer resistance protein | [1] | ||
| OAT1 | Transporter Info | Organic anion transporter 1 | [2] | |||
| OAT3 | Transporter Info | Organic anion transporter 3 | [3] | |||
| OATP4C1 | Transporter Info | Organic anion transporting polypeptide 4C1 | [4] | |||
| References | ||||||
| 1 | Identification of ABCG2 as an Exporter of Uremic Toxin Indoxyl Sulfate in Mice and as a Crucial Factor Influencing CKD Progression. Sci Rep. 2018 Jul 24;8(1):11147. | |||||
| 2 | Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1). J Proteome Res. 2011 Jun 3;10(6):2842-51. | |||||
| 3 | The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis. J Biol Chem. 2017 Sep 22;292(38):15789-15803. | |||||
| 4 | SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation. J Am Soc Nephrol. 2009 Dec;20(12):2546-55. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.